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Abstract
Humans are exposed to multiple chemicals on a daily basis instead of to just a single chemical, yet the majority of existing 
toxicity data comes from single-chemical exposure. Multiple factors must be considered such as the route, concentration, 
duration, and the timing of exposure when determining toxicity to the organism. The need for adequate model systems (in 
vivo, in vitro, in silico and mathematical) is paramount for better understanding of chemical mixture toxicity. Currently, 
shortcomings plague each model system as investigators struggle to find the appropriate balance of rigor, reproducibility 
and appropriateness in mixture toxicity studies. Significant questions exist when comparing single-to mixture-chemical 
toxicity concerning additivity, synergism, potentiation, or antagonism. Dose/concentration relevance is a major considera-
tion and should be subthreshold for better accuracy in toxicity assessment. Previous work was limited by the technology 
and methodology of the time, but recent advances have resulted in significant progress in the study of mixture toxicology. 
Novel technologies have added insight to data obtained from in vivo studies for predictive toxicity testing. These include new 
in vitro models: omics-related tools, organs-on-a-chip and 3D cell culture, and in silico methods. Taken together, all these 
modern methodologies improve the understanding of the multiple toxicity pathways associated with adverse outcomes (e.g., 
adverse outcome pathways), thus allowing investigators to better predict risks linked to exposure to chemical mixtures. As 
technology and knowledge advance, our ability to harness and integrate separate streams of evidence regarding outcomes 
associated with chemical mixture exposure improves. As many national and international organizations are currently stress-
ing, studies on chemical mixture toxicity are of primary importance.
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Introduction to chemical mixtures
In real life, humans are constantly exposed to a variety 
of chemicals most often present as complex mixtures via 
multiple routes of exposure. Chemical mixtures range from 
simple combinations of a few chemicals to a complete, 
integrated exposure profile known as the exposome, that 
is, cumulative exposure to environmental stressors over a 
lifetime. However, even newly developed approaches such 
as grouping of chemicals for cumulative risk assessment 
are not considering real-life exposure scenarios as outlined 
in a recent editorial by Tsatsakis et al. (2019a). Further-
more, particular attention should be given to the exposures 
occurring at critical life periods when assessing risk from 
chemical exposures (Sarigiannis and Karakitsios 2018).
According to the World Health Organization (WHO)/
International Programme on Chemical Safety (IPCS) 
framework (Meek 2013), exposure to the same substance 
from multiple sources and by multiple routes is described 
as ‘‘single chemical, all routes’’ (aggregate exposure). 
Exposure to ‘‘multiple chemicals by a single route’’ can 
be distinguished from exposure to ‘‘multiple chemicals 
by multiple routes’’ (cumulative exposure). In practice, 
humans can be exposed to chemical mixtures as a result of 
sequential exposure to individual chemicals or from con-
current exposure to multiple chemicals through the same 
route or different routes (i.e., oral, dermal, or inhalation). 
Chemicals are considered to co-occur if their toxicoki-
netic/toxicodynamic profiles are such that the chemicals 
or their biological effects are present within an organism 
at the same time (Nelms et al. 2018).
Assessing the risk from exposure to multiple chemicals 
by multiple routes represents a scientific challenge. Inter-
est in this field has intensified over the past decades as evi-
denced by the increasing number of articles appearing in 
the scientific literature (e.g., Feron et al. 1998; Wilkinson 
et al. 2000; Monosson 2005; Boobis et al. 2011; Sarigi-
annis and Hansen 2012; Hernández et al. 2013; Kienzler 
et al. 2016; Hernández and Tsatsakis 2017) and the vari-
ous meetings, technical reports, programs and documents 
claiming the need for additional research into the risk 
assessment of chemical mixtures (Bopp et al. 2015; Quig-
not et al. 2015; Rotter et al. 2017; ATSDR 2018).
There is a pressing need to develop methods, in par-
ticular with regard to their regulatory application, that are 
able to assess the health effects that may be produced by 
exposure to chemical mixtures with the aim of minimiz-
ing or preventing the risk of developing diseases (Kost-
off et  al. 2018; Webster 2018). In general, the hazard 
of chemical mixtures can be assessed as a whole, using 
whole-mixture approaches (Wade et al. 2002; Docea et al. 
2018, 2019; Taghizadeh et al. 2019), or predicted based on 
individual components of the mixture (component-based 
approach), depending on the available data. The whole-
mixture approach is frequently applied for environmental 
samples, as it has the advantage of assessing the toxicity 
of mixtures of unknown composition and unknown poten-
tial for interactions, and measures directly the combined 
effect of the complete mixture. Although this approach 
is increasingly being used in situations of unknown and 
varying composition, such as chemical pollutants in sur-
face water and wastewater effluents, the whole-mixture 
effect data are available for a limited number of mix-
tures and the substances driving the overall response 
frequently remain unidentified as well as potential inter-
actions amongst mixture components (Bopp et al. 2019; 
Hernández et al. 2017). Conversely, the component-based 
approach requires identification of the chemicals present 
in the mixture of concern (e.g., concentration, mode of 
action (MoA) and toxicity of the components of the mix-
ture, which is often lacking) followed by mathematical 
modeling to predict their joint action based on informa-
tion from each individual component of the mixture. The 
missing information can be addressed using novel tech-
nologies which enable a mechanistic understanding of the 
combined effects or can be estimated in part using com-
putational models (see “Mechanism-based methodologies 
for the evaluation of the impact of chemical mixtures on 
human health”). However, component-based approaches 
can potentially lead to underestimations of hazard when 
the composition of a mixture is not fully known, which is 
usually the case, except for clearly defined, intentionally 
manufactured products (e.g., pesticide formulations), or 
chemicals present in foodstuff (e.g., multiple residues of 
pesticides) (Bopp et al. 2019; Hernández et al. 2017).
The component-based approach relies on the concept of 
additivity, which includes dose addition and independent 
action models. The mathematical approach depends mainly 
on whether the chemicals act by the same MOA or by inde-
pendent MOA (Groten et al. 2001). Generally, the concept 
of dose or concentration (often used in ecotoxicology) addi-
tion is applied to substances with similar MOA, and in the 
case of substances with dissimilar MOA, response addition 
is applied. For dose addition, the effects of a mixture of 
compounds can be predicted from the sum of the dose or the 
concentration of similarly acting substances after adjusting 
for the individual differences in potencies. Models assum-
ing dose addition are the most frequently applied because 
they provide reliable estimates of combined effects and are 
appropriate for the risk assessment of chemical mixtures 
when their individual components share the same molecu-
lar mechanism of action. A robust body of experimental 
evidence indicates that the basic assumption of additivity 
offers a reasonable expectation of mixture toxicity assum-
ing that the components of the mixture do not interact with 
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each other, which can modify the magnitude and even the 
nature of the toxic effect (Bopp et al. 2019; Hernández et al. 
2017). The European Food Safety Authority (EFSA) EFSA 
Panel on Plant Protection Products and their Residues (2013) 
recommended the use of methodologies derived from dose 
addition for the assessment of mixtures of pesticides with 
dissimilar MOA, provided they produce a common adverse 
outcome as no cumulative risk assessment method has been 
derived from independent action. Furthermore, other Euro-
pean Union Scientific Committees have recommended the 
use of the dose/concentration addition approach as a prag-
matic and precautious default assumption if no MOA data 
are available since this concept is generally regarded as more 
protective (Bopp et al. 2018). Recently, refined approaches 
have been developed for risk characterization of chemical 
mixtures, accounting for aggregate exposures and using 
toxicological reference values referred to the same critical 
effect/endpoint produced by the individual components of 
the mixture (Goumenou and Tsatsakis 2019). This method-
ology proposed new approaches for the risk characterization 
of single chemicals and chemical mixtures by introducing 
the source-related Hazard Quotient (HQs) and Hazard Index 
(HI) and the adversity-specific Hazard Index (HIa). This 
methodology can be used for any kind of adverse effects 
and endpoints as shown in case studies determining HQs 
for PCBs in fish (Renieri et al. 2019) and HQs and HIa for 
pesticides in pistachio (Taghizadeh et al. 2019).
The question of whether larger adverse effects occur from 
a chemical mixture than would be predicted by adding the 
dose or response of each individual substance is of particu-
lar concern (Rotter et al. 2017; SAPEA (Science Advice 
for Policy by European Academies) 2018; Schäffer et al. 
2018) as it indicates that an interaction may be occurring 
(Hernández and Tsatsakis 2017; Hernández et al. 2017). The 
term interaction includes all forms of joint action that could 
deviate from the abovementioned additivity concepts, i.e., a 
greater effect (synergistic, potentiating, supra-additive), or 
a lesser effect (antagonistic, inhibitive, sub-additive, infra-
additive). As some of these concepts describing deviations 
from additivity are usually a matter of controversy, a proper 
and unambiguous definition is needed. The three main forms 
of interactions are (a) potentiation, which occurs when the 
toxicity of a chemical on a certain tissue or organ system is 
enhanced when given together with another chemical that 
alone does not have toxic effects on the same tissue or organ 
system; (b) synergism, which can result from chemicals act-
ing simultaneously in different molecular or cellular targets 
from toxicity pathways, thus magnifying their final toxic 
effect, with deviations from additivity-based predictions 
being within a factor of four at environmentally realistic con-
centrations; (c) antagonism, a phenomenon that occurs when 
two or more chemicals in a mixture have an overall effect 
that is less than the sum of their individual effects, either as a 
result of toxicokinetic interactions (one chemical may stimu-
late the metabolism of a second one or somehow interfere 
with its absorption or distribution) or toxicodynamic interac-
tions (chemicals elicit the opposite effects by acting on the 
same or different molecular targets, such as enzymes and 
receptors) (Boobis et al. 2011; Bopp et al. 2019; Hernández 
et al. 2013, 2017).
The early toxicology literature contains many unjustified 
claims of synergism or antagonism based on inadequate 
study design as reviewed by Boobis et al. (2011) and Borgert 
et al. (2001) who presented five criteria that studies exam-
ining toxicological interaction in mixtures should consider 
(Table 1). These criteria can be applied broadly to interac-
tion studies for drugs, pesticides, industrial chemicals, food 
additives, and natural products, although compliance with 
them does not necessarily render the results of an interaction 
study suitable for every purpose or every risk assessment. 
The focus on chemical interaction, particularly at environ-
mentally relevant concentrations, using valid toxicological 
and statistical tests, has been reported in a few experimen-
tal studies (Ćurčić et al. 2012; Buha et al. 2013; Zhu et al. 
2014; Chen et al. 2016; Curcic et al. 2017) and represents an 
important step toward advancing human and environmental 
risk assessments for chemical mixtures.
Another important shortcoming of many mixture studies 
is the fact that they often characterize the interactions of 
chemicals at high doses instead of using realistic environ-
mental or dietary exposures. Hence, they do not provide the 
necessary data to support risk management. It is, therefore, 
important that mixture studies examine the low-dose region 
of the dose–response curve with doses at or below the No 
Table 1  Criteria for the evaluation of interaction in toxicological tests (based on Borgert et al. 2001)
Criteria
1 Adequate dose–response curves for the mixture components
2 Explicitly stated “no-interaction” hypothesis
3 Combination of mixture components assessed across a sufficient range of exposure levels and mixing ratios
4 Formal statistical tests used to distinguish whether the response is different than predicted by “no-interac-
tion” hypothesis
5 Interactions should be assessed at relevant levels of biological organization
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Observed Adverse Effect Levels (NOAEL) for the individual 
components of the mixture. To this end, experiments should 
have sufficient statistical power to detect effects at these 
lower doses (Simmons et al. 2018). For this reason, novel 
methodological approaches simulating real-life exposures 
should be developed to assess the potential adverse health 
effects of long-term low-dose exposure to chemical mix-
tures simulating complex real-life human exposures (Tsat-
sakis et al. 2016, 2017, 2019b; Docea et al. 2018, 2019). 
Furthermore, special attention should be given to statistical 
methodologies used in these studies (Sun et al. 2013; Laza-
revic et al. 2019).
One important issue of mixture assessment is when expo-
sure to toxicologically similar chemicals (i.e., with structural 
and/or biological outcome similarity) occurs at levels below 
the toxicological reference values for the individual compo-
nents in the mixture. In this case, the individual risk assess-
ment, performed separately, would conclude that none of the 
chemicals poses a significant risk. However, if the dose addi-
tion approach is applied, the combined exposure might lead 
to significant adverse effects, which are predictable from 
the dose–response curves of the individual components. 
Therefore, it is important to characterize relevant portions 
of the dose–response curves of each individual chemical, 
particularly when the focus is on the low-dose/low-effect 
region (Kostoff et al. 2018; Tsatsakis et al. 2018).
Regardless of the selected approach for the chemical 
mixture risk assessment, it is of paramount importance to 
have data on each individual component of the mixture from 
different lines of evidence. This paper will review the role 
of epidemiological, in vivo, in vitro and some new in silico 
tools in hazard assessment and how these streams of evi-
dence can be combined for mixture risk assessments.
The role and critical assessment 
of the reliability and relevance 
of epidemiology in toxicological prediction 
and risk assessment of chemical mixtures
Basically, epidemiological studies are designed to assess 
whether a certain disease may result from exposure to a 
certain risk factor or whether a particular exposure may 
be associated with a disease in the population. Environ-
mental epidemiological studies rely on observational data 
obtained from cohort, case–control, or cross-sectional 
studies. While associations between chemical exposures 
and biological responses found in these studies are rel-
evant for risk assessment, epidemiological studies cannot 
predict risks associated with exposures that have not yet 
occurred. Hence, predictive risk assessment relies primar-
ily on toxicology studies (Brunekreef 2008). Therefore, 
epidemiology contributes to risk assessment of chemicals 
that have been approved for use and human exposure that 
has already happened. The magnitude of the effect follow-
ing exposure depends on an accurate exposure characteri-
zation using suitable quantitative metrics. The integration 
of existing human biomonitoring (HBM) data can con-
tribute to address combined and aggregate exposure more 
realistically. This approach can identify real-life exposure 
patterns, priority and drivers of mixture toxicity, thus 
allowing potential health risks of mixtures to be assessed 
(Bopp et al. 2018).
Although information from epidemiological studies pro-
vides support for hazard identification and characterization, 
these studies have common factors that restrict the use of 
epidemiological data for risk assessment (Wilks and Tsat-
sakis 2014; Ockleford et al. 2017). These include exposure 
and/or outcome misclassification, and the impact of con-
founding factors on either exposure or health effects. If not 
controlled, confounding can distort the relationship between 
chemical exposure and health outcomes, with this distortion 
either masking a true association or giving rise to a false 
association. Furthermore, epidemiology studies are also 
subject to various forms of bias that hinder causal infer-
ence. In addition, the associations observed may be unrep-
resentative as a consequence of random sampling variation, 
especially when studies include small numbers of individu-
als. Depending on the circumstances, confounding, bias 
and chance may under- or overestimate the health effects 
of a chemical or mixtures. Likewise, classical epidemiol-
ogy often lacks insight into the pathogenesis of the disease, 
thus limiting the characterization of the exposure–response 
relationship (Koureas et al. 2012; Kokkinaki et al. 2014; 
Barrie and Nichols 2015). However, the use of newer and 
novel technologies in modern epidemiological studies (e.g., 
omics) is contributing in part to fill this gap.
In the case of chemical mixtures, it is necessary to know 
the exposure of each person to the individual components 
of the mixture (during critical time windows), the outcome 
of interest, and potential confounders and effect modifiers 
(Webster 2018). Since human exposure to chemicals is not 
characterized by regular, uniform events, exposure assess-
ment needs to account for the frequency, duration and mag-
nitude of the exposure. Reliable ascertainment of exposure 
is particularly challenging when carried out retrospectively, 
especially when the relevant timing of exposure occurred a 
long time before the onset of the disease and the collected 
information relies on the recall of study participants. In turn, 
the use of biomarkers of exposure in biological fluids or 
tissues (i.e., HBM data) represents a useful alternative in 
cases in which the biomarker reflects the relevant metrics of 
exposure. However, as such data are most often generated 
at low levels of exposure, their potential role in causing an 
adverse outcome is not always clear. In such cases, exposure 
needs to be assessed regularly over many years to obtain a 
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reliable measure of long-term cumulative exposure (SAPEA 
(Science Advice for Policy by European Academies) 2018).
For mixture risk assessment, it is a priority to identify 
whether multiple environmental factors, or chemical mix-
tures, are associated with the disease phenotype in human 
populations. New methodological developments that 
improve the scope and quality of epidemiological data on 
chemicals include the use of (a) hypothesis-free, environ-
ment-wide association studies (EWAS); (b) pooled data from 
multiple existing studies; (c) markers of disease processes as 
an outcome (SAPEA (Science Advice for Policy by Euro-
pean Academies) 2018). EWAS assess simultaneously the 
relationships between health outcomes and a wide range of 
chemicals, thus allowing the identification of chemical mix-
tures associated with a particular human disease. Obviously, 
EWAS would greatly benefit from the characterization of 
each individual’s “exposome”. Exposomes can be deter-
mined using personal information (standardized question-
naires, geocodes, etc.), biomonitoring data or environmental 
measurements and prediction models (geospatial models, air 
pollution models, etc.) (Patel 2018).
Regarding health outcomes, these should be clearly and 
unambiguously defined in epidemiological studies to ensure 
that cases are consistently diagnosed and thus avoid potential 
misclassification. Hence, harmonized case definitions are 
encouraged across investigations. Furthermore, surrogate 
outcomes (biomarkers of effects or biochemical measures) 
are generally accepted as substitutes for, or predictors of, 
specific clinical outcomes as they are on the causal pathway 
for the clinical outcome. In contrast to overt clinical disease, 
such biological markers of health allow detection of subtle, 
subclinical toxicodynamic processes. However, often these 
intermediate outcome measures are not validated and do 
not meet the strict definitions of surrogate outcomes. Only 
validated surrogate outcomes indicating an increased risk 
of adverse health effects should be used in epidemiological 
studies (Ockleford et al. 2017; SAPEA (Science Advice for 
Policy by European Academies) 2018).
A variety of statistical methods and approaches is avail-
able for the analysis of complex chemical mixture data in 
both simulated and real-life data sets (Taylor et al. 2016). 
Although novel methods have been applied to assess mix-
tures in epidemiological settings, such as weighted quantile 
sum regression, Bayesian kernel machine regression, and 
exposure space smoothing (Webster 2018), there is no con-
sensus on standard methods for studying chemical mixtures 
in epidemiological studies (Braun et al. 2016). Method-
ologies need to be developed to determine adequately the 
adverse health effects resulting from exposure to combined 
chemicals. Statistical assessment of increasingly complex 
datasets and bioinformatics will provide greater insight into 
the contribution of individual components of chemical mix-
tures to long-term health outcomes (Dennis et al. 2017).
Methodologies for the formal synthesis of epidemiologi-
cal evidence include systematic reviews and meta-analyses. 
These can be used for risk assessment if they have been 
rigorously conducted. Systematic reviews and meta-analyses 
assess the quality and the risk of bias of individual studies 
in a standardized way as well as the quality of reporting. 
Meta-analyses, on the other hand, increase statistical power, 
improve precision of the effect size estimation, provide an 
overall summary measure from conflicting results and assess 
the possibility of publication bias. However, the quality of a 
meta-analysis depends, to a large extent, on the quality of the 
individual studies. Even if the separate studies are of high 
quality, a meta-analysis may not be advisable if there is lack 
of compatibility among studies (e.g., differences in the study 
populations, doses, case definitions, and intensity of surveil-
lance for adverse effects may not be comparable), which 
may lead to large heterogeneity in the results that challenge 
drawing robust conclusions on causality (Ball et al. 2011). 
A recent review of several case studies on human and envi-
ronmental risk assessment of chemical mixtures (Bopp et al. 
2016) identified twenty-one case studies that covered several 
compound classes and environmental media and provided 
clear evidence that chemicals need to be further addressed in 
risk assessment not only as single substances but as mixtures 
and that data sharing regarding toxicity and exposure needs 
to be significantly improved.
The role and critical assessment 
of the reliability and relevance 
of experimental data in toxicological 
prediction and risk assessment of chemical 
mixtures
Evaluation of the potential toxicity of chemicals and phar-
maceuticals in experimental studies is a key element of the 
human safety evaluation. Quantitative risk assessment typi-
cally relies on animal data and extrapolation of this infor-
mation to humans. To this end, regulatory agencies have 
prescribed guidelines to conduct studies to characterize the 
potential toxicity of chemicals (Brunekreef 2008).
Regulatory experimental studies for chemicals are usually 
performed according to harmonized Organisation for Eco-
nomic Co-operation and Development (OECD) test guide-
lines (TG) and conducted following Good Laboratory Prac-
tice (GLP) principles; regulatory testing for drugs generally 
follow the experimental protocols develop by the Interna-
tional Committee on Harmonization (ICH) and also follow 
GLP. However, many of these studies are never published in 
the peer-reviewed literature since they contain proprietary 
information that is subject to confidentiality. For this reason, 
data from peer-reviewed scientific publications, in addition 
to mandatory regulatory toxicology studies, constitute an 
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important part of the database used for the risk assessment 
of chemicals previously approved and marketed, but more 
often than not, such information is not available for newly 
developed chemicals (Kaltenhäuser et al. 2017). Regula-
tory studies typically expose genetically homogenous, 
inbred strains of experimental animals to a range of (usu-
ally high) doses of a chemical under-defined and controlled 
conditions to establish at which dose level chemicals elicit 
clear toxic effects or even death (NRC 2007). These effects 
can be attributed with high certainty to the chemical tested 
and confounding is reduced or even avoided by appropriate 
experimental design. However, such studies require extrapo-
lation from animals to humans, from high to low dose, and 
from single-to multiple-chemical exposures if a mixture is 
being investigated. Unless there is evidence to the contrary, 
findings in animal toxicology studies are generally consid-
ered applicable to humans, although responses of laboratory 
animals and humans to chemicals may differ qualitatively 
and/or quantitatively (Hernández and Tsatsakis 2017).
Unlike regulatory studies, toxicological studies pub-
lished in the peer-reviewed, open literature usually do not 
adhere to harmonized OECD TGs, ICH TGs or to GLP prin-
ciples. Therefore, they need to be evaluated for relevance 
(e.g., whether they are fit-for-purpose) and reliability (e.g., 
whether they are trustworthy in terms of quality and valid-
ity). Their contribution to the overall weight of evidence 
is influenced by the test organism, study design, statistical 
methods, documentation, and reporting of methods and 
results. Criteria for relevance and reliability of toxicologi-
cal data need to be considered when this type of informa-
tion is used for regulatory purposes (Roth and Ciffroy 2016; 
Kaltenhäuser et al. 2017).
The quality and reproducibility of scientific investiga-
tions, in general, have been a topic of considerable interest 
in the scientific community. Besides, when studies are not 
conducted according to accepted guideline protocols, it is 
necessary to consider whether they are sufficiently powered. 
Equally, guideline studies should also include considerations 
of power (Simmons et al. 2018). Criteria for the evaluation 
of the reliability of guideline-compliant/non-guideline stud-
ies are given in Table 2.
For guideline-compliant studies, the respective TGs 
provide harmonized “checklists” to assess the reliability of 
the study. However, adherence to GLP does not guarantee 
methodological quality or error-free experimentation and 
data analysis, nor does it ensure that the study is actually 
relevant for human health risk assessment. Furthermore, 
the lack of adherence of published toxicological studies to 
OECD-TGs does not mean that these studies are not of high 
quality (Kaltenhäuser et al. 2017).
As previously mentioned, another problem when assess-
ing toxicity in animal studies is to adequately design the 
study to make the evaluation of interactions possible. Some 
of the major challenges in developing an experimental 
design for assessing the hazard of chemical mixtures are 
to prioritize chemicals of concern, to set the number of 
mixture components, to define study duration and relevant 
dose concept, to identify the critical end point, to model 
dose–response relationship and to adequately interpret 
obtained results in relation to the effect(s) induced by a sin-
gle component. Theoretically, a vast number of globally rel-
evant chemicals that are proven to have an impact on human 
health will result in an almost indefinite number of possible 
combinations. Additionally, experimental design becomes 
even more complex taking into account how many different 
doses per single chemical, alone or in the mixture, should 
be administered to ensure not only reliable dose–response 
modeling but also respective bases for the analysis of poten-
tial in vivo interactions. The aforementioned number of 
mixture components is multiplied by the number of doses, 
giving thus a total of experimental groups, which should be 
considered in the light of the three Rs principle addressing 
the importance of animal welfare in research and testing. In 
the past, uncritically high doses were used with the aim of 
ensuring clear and unambiguous toxicological effects. It is, 
therefore, of utmost interest to stick to a lower dose concept 
since in the majority of cases low exposures are closer to 
real-life human exposure. Finally, extrapolation of animal 
data to humans is of particular importance, i.e., translation 
of toxic response induced in animals should be sufficiently 
reliable to predict potential adverse health effects as well as 
the safe levels of the chemicals for the human population.
Table 2  Criteria for the evaluation of reliability of guideline-compliant or non-guideline studies (based on Kaltenhäuser et al. 2017)
Substance being tested Basic information on the identity
Test model Transparent and comprehensive description of the test organism of an in vivo study or the model used in an in vitro 
study
Study design Sufficient information on study design to allow others to repeat the study; conducted blind
Test results Presented in a sufficiently accurate, detailed and comprehensible manner
Statistical analysis Allows formalizing the results and weighing their relevance in consideration of the study design. Examination of dose–
response relationships may improve sensitivity and confidence in findings
Reporting of results Results should be reported in sufficient detail
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Pioneer studies trying to shift the current approaches for 
risk assessment toward the aforementioned real-life risk 
assessment simulation (RLRS) approach are emerging. 
These studies are utilizing true exposure scenarios (multiple 
chemicals, multiple adverse outcomes and doses around or 
well below regulatory limits) to derive respective exposure 
limits (Tsatsakis et al. 2016, 2017; Docea et al. 2018, 2019).
Mechanism‑based methodologies 
for the evaluation of the impact of chemical 
mixtures on human health
Novel tools, such as in vitro methods, omics, organs-on-a-
chip, quantitative structure–activity relationships (QSARs), 
read-across, Physiologically Based Toxicokinetic (PBTK) 
modeling, Threshold of Toxicological Concern (TTC), 
Adverse Outcome Pathways (AOP), Dynamic Energy 
Budget (DEB) models and Integrated Approaches to Test-
ing and Assessment (IATA) are being increasingly used in 
risk assessments of mixtures.
In vitro approaches
Significant efforts are being made to move beyond the tra-
ditional empirical assessment of apical toxic endpoints in 
laboratory animals to evaluation of toxicity based on an 
understanding of toxic mechanisms and pathways with 
quantitative determination of relevant parameters through 
in vitro studies. In terms of toxicokinetics, a major limitation 
of many in vitro test systems is that they are usually defi-
cient in enzymes and transporters involved in the disposition 
of chemicals. Furthermore, where the toxic moiety is pre-
sented by an active metabolite instead of the parent chemi-
cal, in vitro models not accounting for the toxicokinetics can 
overlook some toxicity. With respect to toxicodynamics, the 
use of human-based in vitro test systems similar to the target 
cells in vivo enables us to address organ-specific toxicities 
and often to eliminate inter-species differences (SAPEA 
(Science Advice for Policy by European Academies) 2018).
Understanding the MOA can be considered as a start-
ing point in forecasting adverse effects in humans, and such 
approaches often rely on in vitro data (Rouquié et al. 2015). 
Current in vitro systems are suitable to study and identify 
different biomolecules associated with various physiological 
processes where hazard assessment is tracked by testing cell 
lines receptive to specific effects (mechanistic assays). Such 
response to individual chemicals or a combination of chemi-
cal compounds could include activation of receptors and/
or specific pathways, triggering certain intracellular mech-
anisms such as lesion repairing (Polini et al. 2014; Bopp 
et al. 2015). The in vitro assessment of chemical mixtures is 
complex as it can be challenged through top-down (overall 
toxicity caused by complex mixtures) (Tang et al. 2014) and/
or bottom-up methods (chemicals activity checked with a 
variety of in vitro tests) and further combined with chemi-
cal analysis resulting in an Effect directed analysis (EDA) 
(Burgess et al. 2013; Curcic et al. 2014).
In chemical/chemical mixture toxicology, it is essential 
first to evaluate the toxicity profile with in vitro approaches 
that will provide important information related to the MOA 
(toxicodynamics). Such analyses rely basically on cancer 
cell lines, normal cell lines or primary cells maintained in 
standard and controlled conditions, namely a definite time 
period, certain cellular concentrations, level of cellular 
confluency, etc. (Liu et al. 2017). The principal benefit for 
chemical effect assessment is that cellular responses noticed 
through in vitro cell cultures can be evaluated, whereas 
in vivo models might be disturbed by “non-chemical stress-
ors” that can interfere with the real studied effects (Bopp 
et al. 2015).
In vitro batteries can play a pivotal role in toxicity test-
ing, although such systems do not necessarily reproduce the 
precise intercellular interaction or the extracellular envi-
ronment (Polini et al. 2014). The combination of in vitro 
with in vivo approaches represents an excellent progress to 
replace unnecessary in vivo tests. This approach is linked to 
the initiatives implemented by programs such as the ToxCast 
Program from the U.S. Environmental Protection Agency 
(US EPA) and Tox21 of the National Institute of Health 
(NIH) (Bopp et al. 2015; Rouquié et al. 2015). Tox21 is 
an initiative studying a compound’s activity using in vitro 
assays focused mainly on metabolic activity, cellular viabil-
ity and/or intracellular organelle evaluation such as mito-
chondria (Attene-Ramos et al. 2013) and nuclear recep-
tors (Huang et al. 2011). This innovative approach aims to 
develop relevant toxicity methods by screening a large num-
ber of compounds (currently over 10,000) in quantitative 
high-throughput screening platforms. These methods allow 
activity profile patterns to be generated to outline similarity 
between compounds. On the assumption that chemicals with 
similar activity profiles have analogous properties, their toxi-
cological properties may be assessed through read-across 
from a compound’s profile (Hur et al. 2018).
Several in vitro lines are accepted by regulatory organiza-
tions for the assessment of single compounds and/or mix-
tures taking into account their ability to envisage in vivo 
results. For example, the US EPA has accepted the Tox-
Cast Estrogen Receptor model as a substitute for the in vivo 
uterotrophic assay (Browne et al. 2015; Kohno et al. 2018).
Omics‑related tools
In recent years, omic approaches (transcriptomics or gene 
expression profiling, proteomics, metabolomics, and so on) 
are proving to be powerful tools in advancing knowledge 
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regarding toxicological effects and risk assessments. Due 
to their high sensitivity, omic methods are advantageous 
for studying effects occurring at doses which are relevant 
for environmental exposure either to a single chemical or 
a chemical mixture. Since a molecular signature does not 
always produce an adverse outcome at the physiological 
level, proteomic data, although very precise, need to be 
carefully interpreted (Beyer et al. 2014). Nonetheless, 
omics are a valuable tool for toxicity analysis of mixtures 
as well as for single compounds because mechanistic 
insight regarding the MOA and upcoming affected path-
ways can be evaluated and better characterized. Further-
more, in conjunction with standard in vitro methods and 
computational tools, omic technologies have the poten-
tial to offer valuable insight concerning MOA obtained 
in animal models (Brockmeier et al. 2017). Omic meth-
odologies assess if a certain compound induces changes 
that could develop into adverse effects and helps identify 
MOAs. The resulting omic data provide class comparisons 
(which gene/protein best discriminate the studied groups), 
class predictions (the pattern of gene/protein expression 
induced by the test compound to predict the MOA and its 
effects) and class discovery (the case when unpredicted, 
but biologically relevant patterns are generated by omics 
data) (Sauer et al. 2017).
Gene expression microarrays have provided improved 
insights into genetic signatures with the power to discrimi-
nate genotoxic from nongenotoxic carcinogens and/or to 
assess functional effects of chemical exposure. Transcrip-
tomics, among the omics, are the most engaged in providing 
evidence on patterns of cellular alterations and pathways 
and molecular processes affected by chemicals. For the most 
part, this approach had been limited to single-chemical expo-
sures; however, recently transcriptomics studies are being 
used to investigate the effects of mixtures of chemicals (Van 
Delft et al. 2005; Thomas et al. 2007). However, one draw-
back of this approach is related to the lack of clear regula-
tions and validated protocols (Bopp et al. 2015). In contrast 
to classical toxicology methods, transcriptomics can address 
issues such as the physiological behavior of a chemical mix-
ture as a whole or of a specific component in the mixture 
(Moiz Mumtaz et al. 2010). Transcriptomic analysis inves-
tigates differential gene expression at realistic doses known 
to induce specific toxicological reactions, a strategy denoted 
as phenotypic anchoring (Andersen et al. 2018). Moreover, 
gene expression studies have proven to be valuable tools to 
assess MOAs following in-life exposures of experimental 
animals to various chemical compounds or mixtures. Phe-
notypic anchoring belongs to an arsenal of tools including 
heatmaps, pathway enrichment analysis, benchmark dose 
estimations and network representations which are useful 
to assist in patterns of differential gene expression analysis 
of various affected cellular pathways (Andersen et al. 2018).
A novel omics-based strategy in chemicals toxicity 
assessment is to combine in vitro cell-based assays with 
quantitative high-throughput proteomics technology to iden-
tify underlying molecular mechanisms of expected effects, 
and thus predict in vivo responses. In this regard, stem cells 
are a suitable tool because they possess unique proliferation 
and differentiation abilities thus being more physiologically 
relevant than classic standardized cell lines. Such omics-
based assays comprising stem cells would provide mecha-
nistic insights into chemical toxicity and may help for a more 
thorough toxicological assessment (Han et al. 2018).
Organs‑on‑a‑chip
In recent years, development of physiology-relevant experi-
mental models for assessing toxicological effects has become 
a pivotal topic. Thus, in vitro models have evolved from 
2D to 3D settings which authentically mimics inter- and 
extracellular interactions in a living organism. In addition, 
the 3D systems are, in some cases, even surpassing animal 
models that may inexactly depict toxicological effects due 
to inter-species differences. As a consequence, advances in 
microfluidic technologies have allowed 3D organs-on-a-chip 
(OC) design, expanding their usefulness not only in cancer 
and drug toxicity research but also in environmental toxicol-
ogy studies (Pamies et al. 2014; Cho and Yoon 2017; Pamies 
and Hartung 2017).
OC systems consist of tissue constructs and the cultured 
cells displayed on a microfluidic channel networks attempt to 
replicate the human organ structure. The 3D system cells can 
perform most of the in vivo functions (adherence, prolifera-
tion, cell to cell communication, etc.) due to a specific layer 
covering the network channels mimicking the extracellular 
matrix. In addition, a fluid flow is applied in OC to ensure 
a gradient of oxygen, growth factors/nutrients and proper 
intercellular interactions (Inamdar and Borenstein 2011). 
Therefore, these physiology-mimetic microfluidic OC are 
very promising candidates in replacing animal models in 
drug discovery, screening, and assessment of efficacy and 
safety of chemicals (Polini et al. 2014).
Microfluidic 3D devices have been developed that simu-
late various human organs (kidney, liver, gut, and lung) and 
in combining of organs such as a lung/liver chip system. 
These OC systems can play a significant role in understand-
ing the susceptibility of those organs to environmental toxi-
cant exposure.
Several tasks must be considered to obtain accurate 
results when using OC: a tissue-compatible chip material, 
immortalized cell lines versus primary cells, best analytical 
methods to assess OC as the current techniques (typically 
fluorescence microscopy-based) are time-consuming with 
no real-time analysis capacity (Cho and Yoon 2017; Uto 
et al. 2017).
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In silico methods as complement of experimental 
and human observational data
Computer-based (in silico) methods are increasingly used in 
modern chemical risk assessment, particulary as a comple-
ment of experimental and human data since they are a very 
cost-effective means for evaluating mechanistic explana-
tory hypotheses. Thus, in silico approaches can be used in 
cases of missing data, i.e., when the toxicological data are 
not available in published databases or in regulatory assess-
ments. This is all the more true for chemical mixtures due 
to the complexity in assessing actual exposures to mixtures 
and the associated health effects. Thus, the application of in 
silico methods to assess chemical mixtures covers the spec-
trum of risk assessment, from external and internal exposure 
to toxicodynamics and pathology onset and development.
Exposure models
A key problem in exposure modeling in support of complex 
mixture risk assessment is the potential infinity of possible 
mixtures of chemicals that are plausible in the environment 
and/or consumer goods. Machine learning techniques, such 
as frequent itemset mining (FIM), a clustering method used 
widely in marketing studies (Borgelt 2012), may support 
the identification of consumer exposure patterns without 
missing out on the detail of the consumer exposure infor-
mation. Hence, FIM can support the identification of the 
most relevant chemical mixtures for real-life exposures. To 
apply the FIM method, the data must first be converted from 
a concentration matrix into a discretized presence-absence 
matrix. The discretization threshold per compound would be 
derived using a toxicologically relevant criterion (e.g., risk 
characterization ratio, RCR, > 0.05).
The next step in exposure modeling involves the use of 
multimedia chemical fate and transport models. McKay’s 
fugacity III model is the one most widely used and with 
widespread acceptance. A number of multimedia and inte-
grated exposure models that describe the transfer among var-
ious environmental media are practically based on the fugac-
ity approach. The EUSES model system (Lijzen and Rikken 
2004) aims at the evaluation of exposure and the associated 
risks for a broad range of compounds, by directly associat-
ing aggregate exposure to potential adverse outcomes with-
out accounting for internal dosimetry or temporal exposure 
dynamics (Fryer et al. 2004). The Calendex™ model is the 
tool proposed by the US EPA for pesticide exposure assess-
ment, accounting for a broad range of compounds, taken up 
via multiple pathways and routes.
An alternative to the usual approach of multimedia mod-
eling proposed by Pistocchi et al. (2010), focuses on pro-
viding higher spatial resolution of chemical compounds by 
replacing the numerical solution to the advection–dispersion 
equation with local analytical solutions. The Stochastic 
Human Exposure Dose Simulation (SHEDS) system devel-
oped by the US EPA is a continuously evolving modeling 
system, which in its current form allows the investigation of 
complex exposure scenarios, as well as associations to HBM 
data (Zartarian et al. 2002). Recent advances of SHEDS 
have resulted in the Modeling Environment for Total Risk 
studies (MENTOR) (Georgopoulos et al. 2005, 2006, 2008; 
Georgopoulos and Lioy 2006; Lioy et  al. 2007), which 
incorporates internal dosimetry of multiple compounds via 
Multimedia, Multipathway, Multiroute exposures (4 M). 
Similarly, the INTEGRA (Sarigiannis et al. 2014) model 
has been designed in Europe to address both far field expo-
sure resulting from multimedia exchange, as well as within 
near field exposure through indoor microenvironments and 
consumer exposure, integrating all pathways and routes into 
an internal dosimetry model.
In order to represent population exposure starting from 
individual data, probabilistic modeling techniques such as 
Maximum Likelihood Estimation (for variables that fall 
exclusively on normal distributions), Monte Carlo analysis, 
or Bayesian modeling were introduced (Harper 2004; Zidek 
et al. 2005; Mutshinda et al. 2008; Bogen et al. 2009). Fur-
ther to probabilistic modeling, stochastic agent-based models 
(Brandon et al. 2018) refine further exposure estimates on 
the individual and population level by encompassing behav-
ioral dynamics and exposure and risk determinants related 
to sociodemographic characteristics such as socio-economic 
status, age, gender or educational level. By properly describ-
ing these societal dynamics and following the evolution 
of the virtual agents, a more representative description of 
behavioral aspects of exposure can be obtained.
Toxicokinetic (TK) and physiology‑based toxicokinetic 
(PBTK) models
The main aim of TK models is to capture the chemical and 
biochemical kinetics and the biodistribution of xenobiotics 
after exposure. A key function of TK/PBTK models is to 
convert external exposure level to internal dose in biological 
fluids (e.g., blood, urine) and tissues used in HBM stud-
ies, thus permitting the link between external exposure and 
measured HBM levels (Bois et al. 2010). The need for PBTK 
models is increasing, as a result of the continuously grow-
ing concern regarding exposure to multiple chemicals from 
multiple pathways and routes (Yang et al. 2010), and how 
this is translated into temporal dynamics of chemical con-
centrations at the target tissue (Sarigiannis and Karakitsios 
2011; Valcke and Krishnan 2011). Further considerations 
include early life exposures such as in utero (Beaudouin 
et al. 2010), through lactation (Verner et al. 2008) and dur-
ing infancy (Edginton and Ritter 2009). PBTK models are 
capable of capturing multiple chemical interactions at the 
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level of metabolism; however, the lack of sufficient experi-
mental data to describe the interaction terms has resulted in 
a limited number of applications so far, such as in the case of 
volatile organic compounds (VOCs) (Sarigiannis and Gotti 
2008) and metals (Sasso et al. 2010). PBTK models can 
also be used to reconstruct external exposure from HBM 
data. Several numerical methods have been proposed for 
this, mainly categorized into Bayesian and non-Bayesian 
approaches (Georgopoulos et al. 2008). A comprehensive 
method for the implementation of probabilistic exposure 
reconstruction is provided by the Bayesian approach. This 
type of approach has been used in the INTEGRA model, 
based on the Markov Chain Monte Carlo and Differential 
Evolution Markov Chain techniques (Andra et al. 2015; Sari-
giannis et al. 2016).
Physiology‑based toxicodynamic models (PBTD)
PBTD models capture the interaction of xenobiotics with 
molecular targets and how these may be affected by bio-
chemical interactions between mixture components when 
reaching the same or allosterically linked molecular recep-
tors. Thus, they provide a higher level of biological plau-
sibility supporting the derivation of causal dose–response 
relationships in mixture risk assessment.
Pathology models
A comprehensive method to assess risks of long-term effects 
would include the development of a mechanistic approach 
(subject to the constraint that the necessary data are avail-
able) based on a biology-based dose response (BBDR) 
model. BBDR models aim at linking exposure to internal 
dose and by describing computationally the complex bio-
logical processes that result into clinically observed adverse 
health outcomes.
There are two major ways to derive a BBDR:
• The first one is to describe the sequence of biological 
events that culminate in the clinical observations follow-
ing an entirely mechanistic procedure; this requires con-
sideration of all relevant toxicological aspects, following 
the concept of quantitative adverse outcome pathways.
• The second one is to advance the association of epide-
miological data with exposure levels, by linking them 
not only to external exposure estimates, but to internal 
dose, accounting thus for differences in exposure path-
way, route of administration and genetic variability in 
metabolism and clearance.
Aiming at the quantification of risks associated with can-
cer, the multistage approach proposed by Armitage and Doll 
(2004) can be applied, based on the decomposition of the 
dose–response relationship into different micro-relations that 
correspond to different interconnected biological processes 
(Sarigiannis and Gotti, 2008). Constructing dose–response 
relationships based on internal dose provides a stronger bio-
logical basis for extrapolations across different studies, spe-
cies, exposure magnitudes and routes (Aylward et al. 1996; 
Benignus et al. 1998; Melnick and Kohn 2000). This type 
of analysis provides additional insights when co-exposure 
to chemical mixtures results in alterations of the internal 
dose that are reflected in the risk calculation, even if the 
toxic effect is attributed to one of the mixture components. 
This is the case of the ubiquitous chemical mixture BTEX 
(benzene–toluene–ethylbenzene–xylene(s)). Sarigiannis and 
Gotti (2008) developed a BBDR capturing efficiently the 
dose-dependent inhibition of benzene metabolism in humans 
co-exposed to toluene, ethylbenzene and xylenes, a feature 
that although of little consequence at environmental con-
centration levels, becomes highly significant in occupational 
settings at exposure levels close to the regulatory threshold 
limit values.
(Quantitative) structure–activity relationships—(Q)SARs
QSARs are mathematical relations linking molecular attrib-
utes related to chemical structure to biological activity and 
physico/chemical properties. When the description of the 
relationship between chemical structure and molecular 
activity is based only on qualitative descriptors, we refer to 
them as structure–activity relationships (SARs); when this 
description is given in quantitative terms, it is referred to 
as QSARs. Two major types of SAR/QSAR models can be 
distinguished:
• Structural alerts linking the chemical structure of the 
molecule analyzed or the presence of specific chemical 
groups in key positions in the overall molecular configu-
ration with toxicity (e.g., carcinogenicity).
• Chemical models allowing prediction of (a) key descrip-
tors of physico/chemical properties such as kow (octanol–
water partition coefficient, a metric of lipophilicity) 
(Papadaki et al. 2017), which affect toxicokinetic prop-
erties; and (b) biochemical parameters (vmax, Km) that 
determine the quantitative toxicokinetic and toxicody-
namic behavior of chemicals. The latter supports effec-
tively the widespread use of PBTK/TD models in the face 
of data paucity by enabling complex model parameteriza-
tion. Performance of this type of QSARs has improved 
significantly over the last years, by coupling advanced 
QSAR modeling such as the Abraham’s solvation equa-
tion with machine learning algorithms (Sarigiannis et al. 
2017). Use of (Q)SARs for PBTK/TD model parame-
ter estimation is a key enabling technology for further 
development of biology-based dose–response models 
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of chemical mixtures, since it would expand the chemi-
cal space covered by models encompassing biochemical 
interactions among mixture components and between 
these chemicals and co-exposed biological receptors.
Use of adverse outcome pathways (AOPs) 
to structure predictions of toxicity testing—toward 
mechanistic risk assessment
In the last decade, assessment of chemical hazards started 
to move toward mechanistically based approaches. The 
“adverse outcome pathway” (AOP) framework is conceptu-
ally similar to a MOA and originally was described in the 
ecotoxicology community. Now this framework has been 
adopted within an international initiative coordinated by 
the OECD and supported by organizations such as the US 
EPA, the EU’s Joint Research Centre (JRC) and the Euro-
pean Food Safety Authority (EFSA) to assess, document 
and develop potentially predictive testing strategies for 
adverse ecological and human health effects. Since 2012, the 
OECD’s AOP development program has created a knowl-
edge base comprising a set of tools that allow the coordi-
nated development and adoption of AOPs.
An AOP represents a sequence of key events (KE) that 
has a logical flow, as KE are linked through key event rela-
tionships (KER), and take place at various levels of a bio-
logical system upon exposure to chemicals. This exposure 
interacts with specific molecular targets and can trigger a 
chain of events eventually leading to deleterious effects on 
humans or other living organisms. As the scientific informa-
tion progresses, updates are needed focusing on practical 
directions for AOP developers and assessors (OECD Series).
In an AOP, the molecular initiating event (MIE) is defined 
as the point where a chemical directly interacts with a bio-
logical target(s) to create a perturbation. This perturbation 
can develop through a dependent succession of intermediate 
KE and finish with the appearance of an adverse outcome 
(AO); the latter being relevant for the current risk assess-
ment framework. AOPs should describe the critical steps 
along the developed path and these steps should be measur-
able and predictable. Of particular importance are the links 
between upstream and downstream KE, the KERs. They 
should be supported by plausibility and evidence and, ide-
ally, a quantitative understanding. The analytical construct 
of an AOP should include causally interconnected events 
that can generate deleterious health and/or eco-toxicological 
effects (OECD 2018).
It is expected that AOPs will lead to a broader identifica-
tion of testing (e.g, in vivo, in vitro, in chemico) and in silico 
methods. All these newly identified experimental approaches 
can further support regulatory decision-making. This is the 
focus of another OECD initiative, the Integrated Approaches 
to Testing and Assessment (IATA) (Tollefsen et al. 2014). 
An IATA is a pragmatic, science-based approach for chem-
ical hazard characterization that relies on the combined 
analysis of existing information coupled with the genera-
tion of new information using appropriate testing strategies. 
An IATA follows an iterative approach to answer a defined 
question in a specific regulatory context, taking into account 
the acceptable level of uncertainty associated with the deci-
sion context.
In 2018 an extended international survey reported 
that there are major topics that need future development: 
increased communication and stakeholder involvement in 
AOP development and knowledge; increased regulatory use 
and acceptance of the AOP framework; and increased use 
of the AOP framework in applications (Knapen et al. 2018). 
The latest updated guideline also makes reference to AOP 
networks which are formed by the assembly of two or more 
AOPs having one or more shared key events. Various sce-
narios can be envisaged, e.g., a single MIE leading to dif-
ferent AOs, or multiple MIEs converge to a single adverse 
outcome.
On the other hand, although AOPs provide an indica-
tion of the connection between a chemical) and a particular 
disturbance in the organism, they do not necessarily define 
the probability or severity of the AO that can be expected 
under a specified exposure scenario (Conolly et al. 2017). 
Hence, most of AOPs are inappropriate for quantitative 
risk assessment. The term quantitative AOP (qAOP) refers 
to a relatively advanced stage in the progression of AOP 
development and consists of one or more biologically based, 
computational models describing KER linking MIE to the 
AO (Conolly et al. 2017). Although its development can be 
rather resource-intensive, it seems that due to its quantita-
tive, dose–response, and time-course predictions, qAOPs 
will be critical to future regulatory decision-making.
Integration of separate streams of evidence 
(epidemiology, toxicology, mechanistic 
data) for the assessment of chemical 
mixtures toxicity
The awareness of the limitations of observational epide-
miological studies has been used frequently to dismiss or 
reduce a potentially useful body of information. Conversely, 
experimental data have been considered a critical compo-
nent of any well-conducted risk assessment. Human and 
experimental data should be seen as complementary, i.e., 
one emanating from controlled exposures using an experi-
mental study design and a relatively homogeneous surrogate 
population, the other reflecting the changes observed in a 
heterogeneous target population from mixed (and varying) 
exposure conditions using a non-experimental study design 
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(ECETOC (European centre for ecotoxicology and toxicol-
ogy of chemicals) 2009).
Most of the toxicological studies that are required to sup-
port the authorization of regulated chemicals use experi-
mental animals, which are not always predictive of the 
full range of possible adverse outcomes that can occur in 
humans. For instance, complex human diseases (e.g., devel-
opmental neurotoxicity, neurodegenerative diseases, mental 
disorders, some cancers and endocrine disturbances) may 
not be adequately addressed by the standard series of regula-
tory toxicity tests currently in practice. Individually, human, 
experimental and in silico data are not able by themselves 
to capture the pathophysiology of complex apical effects. 
However, a set of assays can provide insight on the diverse 
pathways that can lead to end-organ effects (SAPEA (Sci-
ence Advice for Policy by European Academies) 2018). An 
emerging approach is focusing on the detailed mechanisms 
by which chemicals interact with the body, and on the bio-
chemical pathways that can lead to the adverse outcome or 
disease. All types of evidence addressing the same exposure 
and health endpoints of outcome can be weighted in a sys-
tematic, consistent and transparent way for hazard identifica-
tion using the AOP concept.
The assessment of mixture toxicity needs to address the 
actual pattern of co-exposure in the target population, and 
the adverse health effects posed by the mixture. While the 
former requires valid and reliable methods for exposure 
assessment (measurement and/or modeling), the latter 
approach benefits from the complementary sciences of epi-
demiology and toxicology—in vivo, in vitro, in silico data 
(Webster 2018). The combination of all lines of evidence 
can contribute to a weight-of-evidence analysis in the char-
acterization of human health risks with the aim of improving 
decision-making. Approaches have been proposed by EFSA 
for integration of different streams of evidence in the case of 
pesticides (Ockleford et al. 2017).
Epidemiology plays a special role in risk assessment 
of environmental exposures because it is based on direct 
observations in humans. However, one important limita-
tion of observational epidemiology is the validity of asso-
ciations observed, which are not necessarily causal. Hence, 
information from experimental in vivo and in vitro studies 
complements epidemiology to provide biological plausibly 
and therefore more confidence in the causal interpretation 
of epidemiological findings for risk assessment (Brunekreef 
2008).
For chemicals already marketed, relevant information 
may be available from toxicological and/or epidemio-
logical studies in the peer-reviewed scientific literature. 
A requirement for regulatory decision-making for the re-
approval of chemicals should not be based solely on the 
(non-publicly) available regulatory studies, but should also 
include a systematic review of the published literature to 
collect and synthesize all evidence from non-standardized 
toxicological and epidemiological studies relevant for risk 
assessment (SAPEA (Science Advice for Policy by Euro-
pean Academies) 2018). Then data from multiple lines of 
evidence can be integrated based on a weight-of-evidence 
analysis accounting for relevance, consistency and biological 
plausibility using the modified Bradford Hill criteria (Ockl-
eford et al. 2017). This flexible approach for chemical safety 
assessment based on the integration and translation of the 
data derived from multiple sources and methodologies is 
known as IATA.
Although there is no effective means to read-across health 
outcomes from epidemiological studies with experimental 
findings, basic principles have been proposed as the basis 
for the comparative interpretation of human and experimen-
tal findings. If experimental and human data are concord-
ant it might be assumed that the whole dataset is consistent 
with the hypothesis that the same processes are going on in 
both animals and humans and that, in the event of appropri-
ate exposure, similar toxicities might result. In the case of 
non-concordance, the reasons for the discordance should be 
examined. If the reason is found to be on the basis of the 
underlying biology, then confidence in the risk assessment 
will increase (ECETOC (European centre for ecotoxicology 
and toxicology of chemicals) 2009).
Final reflections
The traditional approach of toxicity testing in which a model 
system is exposed to a single chemical at relatively high 
concentrations to elicit an effect yields limited information 
regarding real-life exposures. This is further complicated by 
the fact that humans are not exposed to a single chemical, 
but to a complex mixture of chemicals at low doses on a 
daily basis. Simply trying to ‘add up’ the different adverse 
outcomes from single chemicals is not sufficient to fully 
understand the nature of these complex chemical/chemical 
interactions. Furthermore, exposure during critical devel-
opmental periods may lay a foundation for increased toxic-
ity to chemicals later in life, with the sequence of chemical 
exposures becoming important in determining the adverse 
outcome. Hence, model systems previously used in toxic-
ity studies may have oversimplified the actions of various 
chemicals. To develop new or improved model systems, 
investigators need to find the appropriate balance of rigor, 
reproducibility and appropriateness of the models used for 
mixture toxicity studies.
When assessing the toxicity of chemical mixtures using 
epidemiological studies important limitations limit the use 
of these data for risk assessment, including exposure and/or 
outcome misclassification, confounding factors and different 
types of bias that challenge the interpretation of the findings. 
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Analysis of chemical mixtures follow the same parameters 
as described above, with time of exposure, duration and 
concentration being vital factors in determining or predict-
ing outcomes. Epidemiological studies can take advantage 
of the use of biomarkers of exposure (e.g., HBM), transla-
tional biomarkers of response (e.g., omics) and biomarkers 
of susceptibility (e.g., toxicogenomics) that contribute to a 
better understanding of the association between exposure 
to chemical mixtures and health outcomes, which is often 
difficult to ascertain.
Recent advances in technologies have resulted in signifi-
cant progress in the study of mixture toxicology. Improved 
technology has added impact to data obtained from new 
in vitro approaches; omics-related tools, organs-on-a-chip 
and 3-D cell cultures, which facilitate high-throughput 
analysis of biomarkers. Improved culture techniques have 
greatly advanced our understanding of a chemical’s action 
at a cellular level and helped gain insight on tumor biol-
ogy. Complex scaffolding or matrices can be used to more 
fully mimic the function of the tissue on an organ level, 
facilitating interpretation of toxicology data from chemi-
cal mixture studies. These strategies, together with in silico 
methods, have improved understanding of toxicity pathways 
and allowed for developing AOP-informed IATA to support 
regulatory decisions.
By understanding the multiple pathways associated with 
adverse outcomes, an investigator is better equipped to pre-
dict risks associated with exposure to chemical mixtures. As 
technology and understanding advance, our ability to har-
ness separate streams of evidence and collectively to provide 
an outcome associated with mixture exposure improves. As 
many national and international organizations are currently 
stressing, studies on chemical mixture toxicity is of primary 
importance. These authorities have stressed the importance 
of conducting studies to address the toxicity of chemical 
mixtures and the significance of developing appropriate 
tools and technologies to facilitate these studies and their 
predictive abilities. The use of AOPs may help our under-
standing of these intricate pathways as they may contain 
multiple branches and intersections. Gaining greater knowl-
edge on the pathways associated with each adverse outcome 
will improve the predictability of all possible outcomes and 
will increase our understanding of the toxicity of chemical 
mixtures.
Clearly the path to understanding the toxicity of chemical 
mixtures is complicated, convoluted and sometimes inter-
twined with other systems, which makes risk assessment a 
complex task. The development and joint use of technologies 
and methodologies across all of the paths, including new 
exposure assessment models, in vitro approaches, omics-
related tools, organs-on-a-chip and 3-D cell culture, in silico 
methods, epidemiological and experimental methods and 
models, will improve risk assessment of chemical mixtures 
and the prioritization of mixtures of concern. Overall, the 
combined use of all these lines of evidence will result in a 
better understanding of AOPs, particularly quantitative ones, 
thus contributing to a better insight into chemical mixture 
toxicity.
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